Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
1997-06-19
2002-09-24
Kunz, Gary L. (Department: 1647)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S320100, C435S325000, C536S023500, C514S012200
Reexamination Certificate
active
06455276
ABSTRACT:
FIELD OF THE INVENTION
This invention concerns the cloning of a novel cDNA sequence encoding a particular subunit of the human GABA
A
receptor. In addition, the invention relates to a stable cell line capable of expressing said cDNA and to the use of the cell line in a screening technique for the design and development of subtype-specific medicaments.
BACKGROUND
Gamma-amino butyric acid (GABA) is a major inhibitory neurotransmitter in the central nervous system. It mediates fast synaptic inhibition by opening the chloride channel intrinsic to the GABA
A
receptor. This receptor comprises a multimeric protein of molecular size 230-270 kDa with specific binding sites for a variety of drugs including benzodiazepines, barbiturates and &dgr;-carbolines, in addition to sites for the agonist ligand GABA (for reviews see Stephenson,
Biochem. J.,
1988, 249, 21; Olsen and Tobin,
Faseb J.,
1990, 4, 1469; and Sieghart,
Trends in Pharmacol. Sci.,
1989, 10, 407).
Molecular biological studies demonstrate that the receptor is composed of several distinct types of subunit, which are divided into four classes (&agr;, &bgr;, &ggr; and &dgr;) based on their sequence similarities. To date, six types of &agr; (Schofield et al.,
Nature
(
London
), 1987, 328, 221; Levitan et al.,
Nature
(
London
), 1988, 335, 76; Ymer et al.,
EMBO J.,
1989, 8, 1665; Pritchett & Seeberg,
J. Neurochem.,
1990, 54, 802; Luddens et al.,
Nature
(
London
), 1990, 346, 648; and Khrestchatisky et al.,
Neuron,
1989, 3, 745), three types of &bgr; (Ymer et al.,
EMBO J.,
1989, 8, 1665), three types of y (Ymer et al.,
EMBO J.,
1990, 9, 3261; Shivers et al.,
Neuron,
1989, 3, 327; and Knoflach et al,
FEBS Lett.,
1991, 293, 191) and one 6 subunit (Shivers et al.,
Neuron,
1989, 3, 327) have been identified.
The differential distribution of many of the subunits has been characterised by in situ hybridisation (Sequier et al.,
Proc. Natl. Acad. Sci. USA,
1988, 85, 7815; Malherbe et al.,
J. Neurosci.,
1990, 10, 2330; Shivers et al.,
Neuron,
1989, 3, 327; and Wisden et al,
J. Neurosci.,
1992, 12, 1040) and this has permitted it to be speculated which subunits, by their co-localisation, could theoretically exist in the same receptor complex.
Various combinations of subunits have been co-transfected into cells to identify synthetic combinations of subunits whose pharmacology parallels that of bona fide GABA
A
receptors in vivo (Pritchett et al.,
Science,
1989, 245, 1389; Malherbe et al.,
J. Neurosci.,
1990, 10, 2330; Pritchett and Seeberg,
J. Neurochem.,
1990, 54, 1802; and Luddens et al.,
Nature
(
London
), 1990, 346, 648). This approach has revealed that, in addition to an &agr; and &bgr; subunit, either &ggr;
1
or &ggr;
2
(Pritchett et al.
Nature
(
London
), 1989, 338, 582; Ymer et al.,
EMBO J.,
1990, 9, 3261; and Malherbe et al.,
J. Neurosci.,
1990, 10, 2330) or y3 (Herb et al.,
Proc. Natl. Acad. Sci. USA,
1992, 89, 1433; Knoflach et al.,
FEBS Lett.,
1991, 293, 191; and Wilson-Shaw et al.,
FEBS Lett.,
1991, 284, 2 11) is also generally required to confer benzodiazepine sensitivity, and that the benzodiazepine pharmacology of the expressed receptor is largely dependent on the identity of the &agr; and &ggr; subunits present. Receptors containing a &dgr; subunit (i.e. &agr;&bgr;&dgr;) do not appear to bind benzodiazepines (Shivers et al.,
Neuron,
1989, 3, 327). Combinations of subunits have been identified which exhibit the pharmacological profile of a BZ
1
type receptor (&agr;
1
&bgr;
1
&ggr;
2
) and a BZ
2
type receptor (&agr;
2
&bgr;
1
&ggr;
2
or &agr;
3
&bgr;
1
&ggr;
2
, Pritchett et al.,
Nature
(
London
), 1989, 338, 582), as well as two GABA
A
receptors with a novel pharmacology, &agr;
5
&bgr;
2
&ggr;
2
(Pritchett and Seeberg,
J. Neurochem.,
1990, 54, 1802) and &agr;
6
&bgr;
2
&ggr;
2
(Luddens et al.,
Nature
(
London
), 1990, 346, 648). Although the pharmacology of these expressed receptors appears similar to that of those identified in brain tissue by radioligand binding, it has nonetheless not been shown that these receptor subunit combinations exist in vivo.
SUMMARY OF THE INVENTION
A combination of subunits comprising either the human &agr;
4
GABA
A
receptor subunit and/or the &dgr; GABA
A
receptor subunit has not hitherto been possible due to the non-availability of the human &agr;
4
cDNA or human &dgr; cDNA. This has consequently limited the use of cell lines in screening for subtype-specific medicaments, it being impossible to study the pharmacological profile of subunit combinations comprising the &agr;
4
subunit and/or the &dgr; subunit.
We have now ascertained the cDNA sequence of the &agr;
4
subunit and the &dgr; subunit of the human GABA
A
receptor. These nucleotide sequences sequence (SEQ ID NO:7 and SEQ ID NO:11), together with their deduced amino acid sequences sequence (SEQ ID NO:8 and SEQ ID NO:12) corresponding thereto, are depicted in
FIGS. 2 and 3
of the accompanying drawings.
The present invention accordingly provides, in a first aspect, a DNA molecule encoding the &agr;
4
subunit of the human GABA
A
receptor comprising all or a portion of the sequence (SEQ ID NO:7) depicted in
FIG. 2
, or a modified human sequence.
The present invention also provides, in another aspect, a DNA molecule encoding the &dgr; subunit of the human GABA
A
receptor comprising all or a portion of the sequence (SEQ ID NO:11) depicted in
FIG. 3
, or a modified human sequence.
The sequencing of the novel cDNA molecules in accordance with the invention can conveniently be carried out by the standard procedure described in accompanying Example 1; or may be accomplished by alternative molecular cloning techniques which are well known in the art, such as those described by Maniatis et al. in
Molecular Cloning, A Laboratory Manual,
Cold Spring Harbor Press, New York, 2nd edition, 1989.
In another aspect, the invention provides a recombinant expression vector comprising the nucleotide sequence of the human GABA
A
receptor &agr;
4
subunit together with additional sequences capable of directing the synthesis of the said human GABA
A
receptor &agr;
4
subunit in cultures of stably co-transfected eukaryotic cells.
The present invention also provides a recombinant expression vector comprising the nucleotide sequence of the human GABA
A
receptor &dgr; subunit together with additional sequences capable of directing the synthesis of the said human GABA
A
receptor &dgr; subunit in cultures of stably co-transfected eukaryotic cells.
REFERENCES:
patent: 5652100 (1997-07-01), Hadingham et al.
patent: 5719057 (1998-02-01), Hadingham et al.
patent: WO 92/22652 (1992-12-01), None
patent: WO 94/13799 (1994-06-01), None
Nakatsu, et al., “A cluster of three GABAA receptor subunit genes is deleted in a neurological mutant of the mouse p locus”, Letters to Nature, vol. 364, Jul. 29, 1993.
Yner, et al., “Sequence and expression of a novel GABA-A receptor alpha subunit”, FEBS Letters, vol. 258, No. 1, pp. 119-122, Nov. 1989.
Togel, et al., “Gamma-Aminobutyric Acid A Receptors Displaying Association of Gamma3 Subunits . . . ”, J. of Biol. Chem., vol. 269, No. 17, pp. 12993-12998, Apr. 29, 1994.
Zhao, et al., “Isolation of Distantly Related Members in a Multigene Family Using the Polymerase Chain Reaction Technique”, Biochem. & Biophys. Res. Comm., vol. 167, No. 1, 1990, pp. 174-182.
Wisden, et al., “GABA-A receptor channels: from subunits to functional entities”, Current Opinion in Neurobiology, vol. 2, No. 3, Jun. 1992, pp. 263-269.
Wisden, et al., “Cloning, pharmacological characteristics and expression pattern of the rat GABA-A receptor alpha-4 subunit”, FEBS Letters, vol. 289, No. 2, pp. 227-230, Sep. 1991.
Le Bourdelles Beatrice
Whiting Paul John
Gucker Stephen
Kunz Gary L.
Merck Sharp & Dohme Ltd.
Tribble Jack L.
Xu Yang
LandOfFree
Human &agr;4 receptor subunit of the GABA-A receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human &agr;4 receptor subunit of the GABA-A receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human &agr;4 receptor subunit of the GABA-A receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2833844